Immune Design news from FierceBiotech
News
Emerging Drug Developer: Immune Design
Immune Design starts recruiting for new research Up until a few years ago, vaccine development was in a torpor. Margins were slim, the manufacturing process difficult and the upside often hard to Read more...
Seattle vaccine developer raises $18M in Series A
Seattle-based Immune Design has raised an impressive $18 million in its first round of venture capital. The vaccine company is developing therapies targeting dendritic cells, which control the human Read more...
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets